165 related articles for article (PubMed ID: 9559629)
21. Effect of perioperative blood transfusions on survival of patients after radical surgery for colorectal cancer.
Leite JF; Granjo ME; Martins MI; Reis RC; Monteiro JC; Castro-Sousa F
Int J Colorectal Dis; 1993 Sep; 8(3):129-33. PubMed ID: 8245667
[TBL] [Abstract][Full Text] [Related]
22. Blood transfusions and local tumor recurrence in colorectal cancer. Evidence of a noncausal relationship.
Busch OR; Hop WC; Marquet RL; Jeekel J
Ann Surg; 1994 Dec; 220(6):791-7. PubMed ID: 7986147
[TBL] [Abstract][Full Text] [Related]
23. Surgical outcomes for colon and rectal cancer over a decade: results from a consecutive monocentric experience in 902 unselected patients.
Andreoni B; Chiappa A; Bertani E; Bellomi M; Orecchia R; Zampino M; Fazio N; Venturino M; Orsi F; Sonzogni A; Pace U; Monfardini L
World J Surg Oncol; 2007 Jul; 5():73. PubMed ID: 17610720
[TBL] [Abstract][Full Text] [Related]
24. Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer.
Betge J; Kornprat P; Pollheimer MJ; Lindtner RA; Schlemmer A; Rehak P; Vieth M; Langner C
Ann Surg Oncol; 2012 Nov; 19(12):3706-12. PubMed ID: 22669453
[TBL] [Abstract][Full Text] [Related]
25. Indicators for surgical resection and intraoperative radiation therapy for pelvic recurrence of colorectal cancer.
Hashiguchi Y; Sekine T; Kato S; Sakamoto H; Nishimura Y; Kazumoto T; Sakura M; Tanaka Y
Dis Colon Rectum; 2003 Jan; 46(1):31-9. PubMed ID: 12544519
[TBL] [Abstract][Full Text] [Related]
26. Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer.
Guller U; Zajac P; Schnider A; Bösch B; Vorburger S; Zuber M; Spagnoli GC; Oertli D; Maurer R; Metzger U; Harder F; Heberer M; Marti WR
Ann Surg; 2002 Dec; 236(6):768-75; discussion 775-6. PubMed ID: 12454515
[TBL] [Abstract][Full Text] [Related]
27. Survival after curative resection for mucinous adenocarcinoma of the colorectum.
Kanemitsu Y; Kato T; Hirai T; Yasui K; Morimoto T; Shimizu Y; Kodera Y; Yamamura Y
Dis Colon Rectum; 2003 Feb; 46(2):160-7. PubMed ID: 12576888
[TBL] [Abstract][Full Text] [Related]
28. Colorectal cancer--a multivariate analysis of prognostic factors.
Wolters U; Stützer H; Keller HW; Schröder U; Pichlmaier H
Eur J Surg Oncol; 1996 Dec; 22(6):592-7. PubMed ID: 9005146
[TBL] [Abstract][Full Text] [Related]
29. Recurrence of colorectal cancer and perioperative blood transfusion. Is blood storage time important?
Hoh H; Umpleby H; Cooper A; Taylor I
Dis Colon Rectum; 1990 Feb; 33(2):127-30. PubMed ID: 2298098
[TBL] [Abstract][Full Text] [Related]
30. Impact of perioperative allogeneic red blood cell transfusion on recurrence and overall survival after resection of colorectal liver metastases.
Schiergens TS; Rentsch M; Kasparek MS; Frenes K; Jauch KW; Thasler WE
Dis Colon Rectum; 2015 Jan; 58(1):74-82. PubMed ID: 25489697
[TBL] [Abstract][Full Text] [Related]
31. [Blood transfusions and prognosis following curative resection of colorectal cancer: is there an association?].
Laffer U; Jäggi P; Harder F; Metzger U; Egeli R; Weber W; Barras JP; Schweizer W; Müller W; Martinoli S
Helv Chir Acta; 1989 Dec; 56(4):461-4. PubMed ID: 2632470
[TBL] [Abstract][Full Text] [Related]
32. Effects of allogeneic blood transfusion in patients with stage II colon cancer.
Meng J; Lu XB; Tang YX; Sun GP; Li X; Yan YF; Liang GF; Ma SP; Li XX
Asian Pac J Cancer Prev; 2013; 14(1):347-50. PubMed ID: 23534751
[TBL] [Abstract][Full Text] [Related]
33. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of metabolic parameters in patients with synchronous colorectal cancer liver metastasis following curative-intent colorectal and hepatic surgery.
Lee HS; Kim HO; Hong YS; Kim TW; Kim JC; Yu CS; Kim JS
J Nucl Med; 2014 Apr; 55(4):582-9. PubMed ID: 24549284
[TBL] [Abstract][Full Text] [Related]
35. Blood transfusion and prognosis in Dukes' B and C colorectal cancer.
Bentzen SM; Balslev I; Pedersen M; Teglbjaerg PS; Hanberg-Sørensen F; Bone J; Jacobsen NO; Sell A; Overgaard J; Bertelsen K
Eur J Cancer; 1990 Apr; 26(4):457-63. PubMed ID: 2141511
[TBL] [Abstract][Full Text] [Related]
36. Impact of perioperative blood transfusion on immune function and prognosis in colorectal cancer patients.
Qiu L; Wang DR; Zhang XY; Gao S; Li XX; Sun GP; Lu XB
Transfus Apher Sci; 2016 Apr; 54(2):235-41. PubMed ID: 26780991
[TBL] [Abstract][Full Text] [Related]
37. Pelvic local recurrence from colorectal cancer: surgical challenge with changing preconditions.
Iversen H; Martling A; Johansson H; Nilsson PJ; Holm T
Colorectal Dis; 2018 May; 20(5):399-406. PubMed ID: 29161761
[TBL] [Abstract][Full Text] [Related]
38. Allogeneic blood transfusion in patients in Dukes B stage of colorectal cancer.
Zdravkovic D; Bilanovic D; Randjelovic T; Granic M; Djukanovic B; Ivanovic N; Dikic S; Nikolic D; Zdravkovic M; Soldatovic I
Med Oncol; 2011 Mar; 28(1):170-4. PubMed ID: 20151229
[TBL] [Abstract][Full Text] [Related]
39. Transfusion does not influence patient survival after resection of colorectal cancer.
Molland G; Dent OF; Chapuis PH; Bokey EL; Nicholls M; Newland RC
Aust N Z J Surg; 1995 Aug; 65(8):592-5. PubMed ID: 7661803
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial.
Riethmüller G; Holz E; Schlimok G; Schmiegel W; Raab R; Höffken K; Gruber R; Funke I; Pichlmaier H; Hirche H; Buggisch P; Witte J; Pichlmayr R
J Clin Oncol; 1998 May; 16(5):1788-94. PubMed ID: 9586892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]